NO20044004L - HFA-Suspensjonsformulering av et anhydrat - Google Patents

HFA-Suspensjonsformulering av et anhydrat

Info

Publication number
NO20044004L
NO20044004L NO20044004A NO20044004A NO20044004L NO 20044004 L NO20044004 L NO 20044004L NO 20044004 A NO20044004 A NO 20044004A NO 20044004 A NO20044004 A NO 20044004A NO 20044004 L NO20044004 L NO 20044004L
Authority
NO
Norway
Prior art keywords
anhydrate
suspension formulation
hfa suspension
hfa
formulation
Prior art date
Application number
NO20044004A
Other languages
English (en)
Norwegian (no)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20044004L publication Critical patent/NO20044004L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20044004A 2002-03-28 2004-09-23 HFA-Suspensjonsformulering av et anhydrat NO20044004L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats
PCT/EP2003/002899 WO2003082244A2 (de) 2002-03-28 2003-03-20 Hfa-suspensionsformulierungen eines anhydrats

Publications (1)

Publication Number Publication Date
NO20044004L true NO20044004L (no) 2004-10-05

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044004A NO20044004L (no) 2002-03-28 2004-09-23 HFA-Suspensjonsformulering av et anhydrat

Country Status (21)

Country Link
EP (1) EP1492498A2 (sr)
JP (1) JP5147158B2 (sr)
KR (1) KR101005717B1 (sr)
CN (1) CN1642525A (sr)
AU (1) AU2003221509B2 (sr)
BR (1) BR0308709A (sr)
CA (1) CA2479638C (sr)
DE (1) DE10214264A1 (sr)
EA (1) EA008610B1 (sr)
EC (1) ECSP045322A (sr)
HR (1) HRP20040890A2 (sr)
IL (1) IL163696A0 (sr)
ME (1) ME00246B (sr)
MX (1) MXPA04009338A (sr)
NO (1) NO20044004L (sr)
NZ (1) NZ536030A (sr)
PL (1) PL371295A1 (sr)
RS (1) RS52481B (sr)
UA (1) UA79776C2 (sr)
WO (1) WO2003082244A2 (sr)
ZA (1) ZA200405637B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5227790B2 (ja) * 2005-05-02 2013-07-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規結晶性臭化チオトロピウム
EP1879888A2 (en) * 2005-05-02 2008-01-23 Boehringer Ingelheim International GmbH Crystalline forms of tiotropium bromide
AU2010253770B9 (en) * 2009-05-29 2015-02-12 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
EP3515439B1 (en) * 2016-09-19 2021-12-15 Mexichem Fluor S.A. de C.V. Pharmaceutical composition comprising tiotropium bromide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP1102579B1 (de) * 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten
JP2004512379A (ja) * 2000-10-31 2004-04-22 ベーリンガー　インゲルハイム　ファルマ　ゲゼルシャフト　ミット　ベシュレンクテル　ハフツング　ウント　コンパニー　コマンディトゲゼルシャフト 新規医薬組成物
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten

Also Published As

Publication number Publication date
JP5147158B2 (ja) 2013-02-20
MXPA04009338A (es) 2005-01-25
IL163696A0 (en) 2005-12-18
WO2003082244A3 (de) 2004-02-05
KR20040098022A (ko) 2004-11-18
AU2003221509A1 (en) 2003-10-13
CA2479638C (en) 2011-01-04
EP1492498A2 (de) 2005-01-05
EA008610B1 (ru) 2007-06-29
MEP47308A (en) 2011-02-10
CN1642525A (zh) 2005-07-20
PL371295A1 (en) 2005-06-13
ME00246B (me) 2011-05-10
RS52481B (sr) 2013-02-28
AU2003221509B2 (en) 2008-01-24
EA200401159A1 (ru) 2005-04-28
KR101005717B1 (ko) 2011-01-05
JP2005527550A (ja) 2005-09-15
BR0308709A (pt) 2005-01-04
YU86004A (sh) 2006-08-17
ECSP045322A (es) 2005-01-28
WO2003082244A2 (de) 2003-10-09
CA2479638A1 (en) 2003-10-09
ZA200405637B (en) 2005-07-27
DE10214264A1 (de) 2003-10-16
NZ536030A (en) 2006-07-28
UA79776C2 (en) 2007-07-25
HRP20040890A2 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
IL230659A (en) Calicheamicin derivative-carrier conjugates
DE60316581D1 (de) 6-alkoxypyridopyrimidine als inhibitoren der p-38-map-kinase
ITMI20021228A1 (it) Composizioni di poliuretani reticolabili
NO20020221D0 (no) Fremgangsmåte for isolasjon av borehull
EP1496894A4 (en) ANGIOGENESIS INHIBITORS
IS7623A (is) Sískammtalausnar töflusamsetning úr pramipexóli
FR2830516B1 (fr) Suspension de turboreacteur
NO20044916L (no) Preparater av sulfinylacetamid
NO20052348D0 (no) Behandling av hemoragisk sjokk
GB0218218D0 (en) Updating of software
DE60310413D1 (de) Luftfederbalg
NO20043937L (no) Anvendelse av vitamin D sammensetninger
NO20052676D0 (no) Polymorfer av bicifadin-saltsyre
NO20041968L (no) Anvendelse av cystationin
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20053203D0 (no) Kombinasjon av lokale esteranestetika.
NO20035605D0 (no) Pediatrisk formulering av gatifloxacin
NO20054188D0 (no) Et arrangement av fagverksstag
DK1492513T3 (da) HFA-suspensionsformuleringer indeholdende et anticholinergikum
NO20043948L (no) Fremstilling av olefiner
IL163696A0 (en) Hfa-suspension formulation of an anhydrate
FI20021406A0 (fi) Densiinitapaisten yhdisteiden käyttö
NO20035409L (no) Universal innfestning av losore
FR2836449B1 (fr) Nouveau type de dirigeable
FR2822468B1 (fr) Derives chimiques et leur application comme agent anti-telomerase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application